These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 35269576)

  • 1. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.
    Labetoulle M; Benitez-Del-Castillo JM; Barabino S; Herrero Vanrell R; Daull P; Garrigue JS; Rolando M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
    Daull P; Amrane M; Ismail D; Georgiev G; Cwiklik L; Baudouin C; Leonardi A; Garhofer G; Garrigue JS
    J Ocul Pharmacol Ther; 2020; 36(6):355-365. PubMed ID: 32493105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations.
    Weng J; Fink MK; Sharma A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of artificial tear treatment on corneal epithelial thickness and corneal topography findings in dry eye patients.
    Çakır B; Doğan E; Çelik E; Babashli T; Uçak T; Alagöz G
    J Fr Ophtalmol; 2018 May; 41(5):407-411. PubMed ID: 29776765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for 24-hour management of dry eye disease: A review.
    Guillon M; Shah S
    Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Development of Artificial Tears Based on an Extract of Artemia Salina Containing Dinucleotides in Rabbits.
    Carpena-Torres C; Pintor J; Huete-Toral F; Rodriguez-Pomar C; Martínez-Águila A; Carracedo G
    Curr Eye Res; 2021 Feb; 46(2):174-178. PubMed ID: 32602751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis.
    Jongkhajornpong P; Anothaisintawee T; Lekhanont K; Numthavaj P; McKay G; Attia J; Thakkinstian A
    Cornea; 2022 Sep; 41(9):1137-1149. PubMed ID: 34924549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment.
    Acar D; Molina-Martínez IT; Gómez-Ballesteros M; Guzmán-Navarro M; Benítez-Del-Castillo JM; Herrero-Vanrell R
    Cont Lens Anterior Eye; 2018 Feb; 41(1):93-96. PubMed ID: 29223649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of Lipid-Based Products in the Management of Dry Eye Disease.
    Garrigue JS; Amrane M; Faure MO; Holopainen JM; Tong L
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):647-661. PubMed ID: 28956698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model.
    Niamprem P; Teapavarapruk P; Srinivas SP; Tiyaboonchai W
    Cornea; 2019 Apr; 38(4):485-491. PubMed ID: 30681516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
    Vandermeer G; Chamy Y; Pisella PJ
    J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
    Srinivasan S; Garofalo R; Williams R
    Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.
    Ribeiro MVMR; Barbosa FT; Ribeiro LEF; Sousa-Rodrigues CF; Ribeiro EAN
    Arq Bras Oftalmol; 2019 Sep; 82(5):436-445. PubMed ID: 31508669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear-film-oriented diagnosis for dry eye.
    Yokoi N; Georgiev GA
    Jpn J Ophthalmol; 2019 Mar; 63(2):127-136. PubMed ID: 30783943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASSESSMENT OF FUNCTIONAL CHANGES TEAR PRODUCTION UNDER THE ACTION OF THE EYE DROPS ON THE BASE OF NATURAL MOLECULE OF ECTOINE AND ARTIFICIAL TEARS IN PATIENTS WITH DRY EYE SYNDROME ON THE BACKGROUND OF ENDOCRINE OPHTHALMOPATHY.
    Veselovskaya NN; Zherebko IB
    Fiziol Zh (1994); 2016; 62(6):118-121. PubMed ID: 29762980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.